Alliance of Infinity Trade
Cefepime Dry Vial Range
Introducing AIT Pharmaceuticals Division’s Cefepime Dry Vial Range
At AIT Pharmaceuticals Division, we are committed to advancing healthcare by providing high-quality pharmaceutical products to healthcare professionals worldwide. Our Cefepime Dry Vial Range exemplifies our dedication to excellence in antibiotic therapy, offering a potent solution for a wide range of bacterial infections.
Drug Classification: Cefepime belongs to the class of fourth-generation cephalosporin antibiotics, renowned for their broad spectrum of activity against Gram-positive and Gram-negative bacteria, including many multi-drug resistant strains.
Share
Formulations:
- Cefepime Dry Vial: Available in multiple strengths, including 250mg, 500mg, 1000mg, and 2000mg, our vials contain a sterile powder for reconstitution, providing flexibility and convenience for healthcare providers.
Indications:
- Our Cefepime Dry Vial is indicated for the treatment of various infections caused by susceptible organisms, including:
- Lower respiratory tract infections, such as pneumonia
- Urinary tract infections, including complicated urinary tract infections (cUTIs) and pyelonephritis
- Skin and soft tissue infections, including cellulitis and diabetic foot infections
- Intra-abdominal infections, such as peritonitis
- Septicemia
- Febrile neutropenia
- Empiric therapy in febrile patients with neutropenia
- Nosocomial pneumonia
Pharmacokinetics:
- Absorption: Cefepime is administered intravenously and achieves rapid and complete absorption into the systemic circulation.
- Distribution: The drug distributes widely into various body tissues and fluids, including the lungs, kidneys, liver, and cerebrospinal fluid.
- Metabolism: Cefepime undergoes minimal metabolism in the liver, with approximately 90% of the unchanged drug excreted in the urine within 24 hours.
- Elimination: The elimination half-life of cefepime is approximately 2 hours in adults with normal renal function.
Pharmacodynamics:
- Cefepime exerts its bactericidal effect by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, leading to cell death.
Usage:
- Our Cefepime Dry Vial is intended for intravenous administration by healthcare professionals trained in the proper handling and reconstitution of injectable medications.
Dosage:
- The dosage of Cefepime Dry Vial varies depending on the type and severity of the infection, as well as the patient’s age, weight, and renal function.
- Dosage adjustments may be necessary in patients with impaired renal function to prevent drug accumulation and toxicity.
Side Effects:
- Common side effects of Cefepime may include:
- Nausea and vomiting
- Diarrhea
- Headache
- Injection site reactions, such as pain and inflammation
- Serious side effects such as hypersensitivity reactions, Clostridium difficile-associated diarrhea, and superinfections may occur, although they are rare.
Experience the effectiveness and reliability of AIT Pharmaceuticals Division’s Cefepime Dry Vial Range in the treatment of bacterial infections. For more information, please contact us.
Reviews
There are no reviews yet.